Spyre Therapeutics
SYRE
#5838
Rank
โ‚ฌ0.70 B
Marketcap
11,67ย โ‚ฌ
Share price
-8.58%
Change (1 day)
-64.26%
Change (1 year)

Earnings for Spyre Therapeutics (SYRE)

Earnings in 2024 (TTM): -โ‚ฌ0.2 Billion

According to Spyre Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -โ‚ฌ0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spyre Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ0.2 Billion62.23%
2023 -โ‚ฌ0.12 Billion51.64%
2022 -โ‚ฌ77.34 Million29.14%
2021 -โ‚ฌ59.89 Million-19.43%
2020 -โ‚ฌ74.33 Million1.43%
2019 -โ‚ฌ73.29 Million76.7%
2018 -โ‚ฌ41.48 Million64.27%
2017 -โ‚ฌ25.25 Million26.34%
2016 -โ‚ฌ19.99 Million93.6%
2015 -โ‚ฌ10.33 Million27.08%
2014 -โ‚ฌ8.13 Million